Patent ID: 7289847

Claim:
A method of treating atrial fibrillation comprising: (a) sensing activity of a heart; (b) analyzing the activity to detect atrial fibrillation in the heart; (c) classifying the atrial fibrillation as one of a plurality of atrial fibrillation types including: Type I, wherein Type I comprises discrete organized atrial EGMs with intervening isoelectric lines free of perturbation; Type II, wherein Type II comprises discrete organized atrial EGMs without clear isoelectric intervals; Type III, wherein Type III comprises disorganized atrial EGMs without clear isoelectric intervals; and Type IV, wherein Type IV is characterized as alternations between Type I and Type III; (d) selecting a therapy from a plurality of therapies, wherein the therapy for Type I and Type II atrial fibrillation is ATP therapy, and the therapy for Type III and Type IV atrial fibrillation is a hybrid therapy, wherein the hybrid therapy is a combination of ATP therapy and drug therapy; and (e) delivering the selected therapy to the heart.